Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2-endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study

Simple item page
dc.conference.dateMAY 05-08, 2021
dc.conference.titleESMO Breast Cancer Virtual Congress
dc.contributor.authorTibau, A.
dc.contributor.authorMartinez, M. T.
dc.contributor.authorRamos, M.
dc.contributor.authorDe la Cruz-Merino, L.
dc.contributor.authorSantaballa, A.
dc.contributor.authorO'Connor, M.
dc.contributor.authorMartinez-Janez, N.
dc.contributor.authorMoreno, F.
dc.contributor.authorFernandez-Perez, I.
dc.contributor.authorVirizuela, J. A.
dc.contributor.authorAlarcon, J.
dc.contributor.authorde la Haba-Rodriguez, J.
dc.contributor.authorSanchez-Rovira, P.
dc.contributor.authorAlbacar, C. R.
dc.contributor.authorBueno, C.
dc.contributor.authorKelly, C.
dc.contributor.authorCasas, M.
dc.contributor.authorBezares, S.
dc.contributor.authorRosell, L.
dc.contributor.authorAlbanell, J.
dc.contributor.authoraffiliation[Tibau, A.] Hosp Santa Creu & Sant Pau, GEICAM Breast Canc Grp, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Martinez, M. T.] Hosp Clin Univ Valencia, Med Oncol, Inst Invest Sanitaria INCLIVA, GEICAM Breast Canc Grp, Valencia, Spain
dc.contributor.authoraffiliation[Ramos, M.] Ctr Oncol A Coruna, Oncol, GEICAM Breast Canc Grp, La Coruna, Spain
dc.contributor.authoraffiliation[De la Cruz-Merino, L.] Univ Seville, Hosp Univ Virgen de la Macarena, GEICAM Breast Canc Grp, Oncol,Med Dept, Seville, Spain
dc.contributor.authoraffiliation[Santaballa, A.] Hosp Univ & Politecn La Fe, GEICAM Breast Canc Grp, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[O'Connor, M.] Univ Hosp Waterford, Oncol, Canc Trials Ireland, Waterford City, Ireland
dc.contributor.authoraffiliation[Martinez-Janez, N.] Hosp Univ Ramon y Cajal, GEICAM Breast Canc Grp, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Moreno, F.] Hosp Clin Univ San Carlos, GEICAM Breast Canc Grp, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Fernandez-Perez, I.] Hosp Alvaro Cunqueiro, GEICAM Breast Canc Grp, Med Oncol, Vigo, Spain
dc.contributor.authoraffiliation[Virizuela, J. A.] Hosp Quiron SaludSagrado Corazon, GEICAM Breast Canc Grp, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Alarcon, J.] Hosp Univ Son Espases, GEICAM Breast Canc Grp, Med Oncol, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[de la Haba-Rodriguez, J.] Univ Cordoba, Inst Maimonides Invest Biomed, Hosp Reina Sofia Hosp, Med Oncol,GEICAM Breast Canc Grp,CIBERONC ISCIII, Cordoba, Spain
dc.contributor.authoraffiliation[Sanchez-Rovira, P.] Hosp Univ Jaen, GEICAM Breast Canc Grp, Med Oncol, Jaen, Spain
dc.contributor.authoraffiliation[Albacar, C. R.] Hosp Univ St Joan Reus, GEICAM Breast Canc Grp, Med Oncol, Reus, Spain
dc.contributor.authoraffiliation[Bueno, C.] Hosp Univ Infanta Cristina, GEICAM Breast Canc Grp, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Kelly, C.] Mater Misericordiae Univ Hosp, Canc Trials Ireland, Med Oncol, Dublin, Ireland
dc.contributor.authoraffiliation[Casas, M.] GEICAM Breast Canc Grp, Dept Stat, San Sebastian De Reyes, Spain
dc.contributor.authoraffiliation[Bezares, S.] GEICAM Breast Canc Grp, Sci, San Sebastian De Reyes, Spain
dc.contributor.authoraffiliation[Rosell, L.] GEICAM Breast Canc Grp, Clin Operat, San Sebastian De Reyes, Spain
dc.contributor.authoraffiliation[Albanell, J.] Pompeu Fabra Univ, GEICAM Breast Canc Grp, Hosp del Mar, Med Oncol,IMIM,CIBERONC ISCIII, Barcelona, Spain
dc.contributor.funderGEICAM Spanish Breast Cancer Group
dc.date.accessioned2025-01-07T13:37:43Z
dc.date.available2025-01-07T13:37:43Z
dc.date.issued2021-05-08
dc.identifier.doi10.1016/j.annonc.2021.03.108
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753421009868/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25703
dc.identifier.wosID648924400098
dc.issue.number2
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.organizationSAS - Hospital Universitario de Jaén
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS63-S63
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleQuality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2-endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario de Jaén
SAS - Hospital Universitario Virgen del Rocío
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía